Hepatocellular carcinoma in a non-cirrhotic liver with a tumor thrombus

Abid M Sadiq1,2, Tendai J Mashonganyika3, Lilian G Mmbaga4

  • 1Department of Internal Medicine Kilimanjaro Christian Medical Centre Moshi Tanzania.

Clinical Case Reports
|September 13, 2021
PubMed

Insights

Young adults with hepatocellular carcinoma (HCC) often receive a poor prognosis due to late-stage diagnosis. Early screening and diagnosis, particularly for Hepatitis B surface antigen (HBsAg)-positive individuals, are crucial for improving outcomes in this demographic.

Area of Science:

  • Hepatology
  • Oncology
  • Viral Hepatitis Research

Background:

  • Hepatocellular carcinoma (HCC) presents a significant challenge in young adults, often diagnosed at advanced stages.
  • Despite preserved liver function, young adults with HCC typically experience poor prognoses.
  • Hepatitis B virus (HBV) infection, indicated by Hepatitis B surface antigen (HBsAg) positivity, is a known risk factor for HCC.

Observation:

  • Young adult patients with HCC are frequently diagnosed with advanced disease.
  • Preserved liver function in young adults does not necessarily correlate with a better prognosis for HCC.
  • HBsAg-positive status appears to be a critical factor influencing prognosis in young adults with HCC.

Findings:

  • Young adults with HCC demonstrate a poor prognosis primarily due to the advanced stage at diagnosis.
  • Early detection strategies are essential for improving survival rates in young adults with HCC.
  • Targeted screening in HBsAg-positive young adults may lead to earlier diagnosis and better HCC outcomes.

Implications:

  • The findings underscore the need for enhanced surveillance programs for HCC in young adults.
  • Implementing early diagnostic measures could significantly alter the clinical trajectory for young HCC patients.
  • Focusing screening efforts on HBsAg-positive young adults could be a key strategy in reducing HCC mortality.

Related Concept Videos